CXC-AG
CXC-AG is a division of CXC, solely focused on developing and commercializing research from top university laboratories. CXC-AG has strong links to McGill University, especially the Smith Lab which is renowned for developing lipochito-oligosaccharides (LCOs), which are arguably the biggest hit in biologicals, in use on hundreds of millions of acres worldwide.
Biologicals
BioFuelNet Canada Inks Research Deal with CXC-AG for 450 Bacterial Strains to Fight GHGs
The new strains have the potential to increase yields in the absence of abiotic stress.
Latest News
Biostimulants
BioConsortia Appoints Matthew Mouw as Vice President of Business Development
Agricultural technology executive brings deep experience across biologicals, seed...
ABG Update Feature
AgriBusiness Global Report: The Future of Biostimulants: Key Market Trends, Single-Molecule Tech, Grower Adoption
Stephen Pearce, Chairman of Accumont, and Sebastian Bachem, CEO...
Agrochemicals
ADAMA Appoints Dr. Zhigang Hao as President and CEO and Sammy Leibowitz as Chief Financial Officer
Global leadership experience and deep ADAMA expertise to support...
Americas
Cogny Secures Brazil’s First Authorization for Industrial Use of GMOs in Biocontrol Inputs
Historic regulatory approval positions Cogny to advance biotechnology-driven biological...